Homocysteine and copper ions: is their interaction responsible for cardiovascular-related damage? - PubMed (original) (raw)

Homocysteine and copper ions: is their interaction responsible for cardiovascular-related damage?

Dimitrios Tsikas. Amino Acids. 2021 Aug.

No abstract available

PubMed Disclaimer

Conflict of interest statement

The author reports no conflicts of interest.

Similar articles

• Reply to homocysteine and copper ions: is their interaction responsible for cardiovascular‑related damage?
  Strongin RM. Strongin RM. Amino Acids. 2021 Aug;53(8):1299-1300. doi: 10.1007/s00726-021-03022-7. Epub 2021 Jul 1. Amino Acids. 2021. PMID: 34196788 No abstract available.
• Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage.
  Gupta M, Meehan-Atrash J, Strongin RM. Gupta M, et al. Amino Acids. 2021 May;53(5):739-744. doi: 10.1007/s00726-021-02979-9. Epub 2021 Apr 22. Amino Acids. 2021. PMID: 33886000
• Copper and homocysteine in cardiovascular diseases.
  Kang YJ. Kang YJ. Pharmacol Ther. 2011 Mar;129(3):321-31. doi: 10.1016/j.pharmthera.2010.11.004. Epub 2010 Dec 1. Pharmacol Ther. 2011. PMID: 21130114 Review.
• Folate and homocysteine.
  Young IS, Woodside JV. Young IS, et al. Curr Opin Clin Nutr Metab Care. 2000 Nov;3(6):427-32. doi: 10.1097/00075197-200011000-00003. Curr Opin Clin Nutr Metab Care. 2000. PMID: 11085827 Review.
• Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties.
  Cacciapuoti F. Cacciapuoti F. J Thromb Thrombolysis. 2011 Jul;32(1):82-8. doi: 10.1007/s11239-011-0550-4. J Thromb Thrombolysis. 2011. PMID: 21234645 Review.

References

1. 1. Arora B, Narayanasamy A, Nirmal J, Halder N, Patnaik S, Ravi AK, Velpandian T. Development and validation of a LC-MS/MS method for homocysteine thiolactone in plasma and evaluation of its stability in plasma samples. J Chromatogr B Anal Technol Biomed Life Sci. 2014;944:49–54. doi: 10.1016/j.jchromb.2013.11.011. - DOI - PubMed
2. 1. Esse R, Barroso M, de Almeida IT, Rita Castro R. The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art. Int J Mol Sci. 2019;20(4):867. doi: 10.3390/ijms20040867. - DOI - PMC - PubMed
3. 1. Giustarini D, Dalle-Donne I, Tsikas D, Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci. 2009;46(5–6):241–281. doi: 10.3109/10408360903142326. - DOI - PubMed
4. 1. Gupta M, Meehan-Atrash J, Strongin RM. Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage. Amino Acids. 2021;53:739–744. doi: 10.1007/s00726-021-02979-9. - DOI - PubMed
5. 1. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem. 1992;200(2):218–229. doi: 10.1016/0003-2697(92)90456-H. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information